Does Zyprexa (olanzapine) come in an intravenous (IV) formulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Zyprexa (Olanzapine) Come in IV Formulation?

No, Zyprexa (olanzapine) does not come in an intravenous (IV) formulation—it is available only as intramuscular (IM) injection for parenteral use, along with oral formulations. 1

Available Formulations

Olanzapine is available in the following forms:

  • Intramuscular (IM) injection: Approved for acute agitation in schizophrenia and bipolar mania 1, 2
  • Oral tablets: Standard immediate-release formulation 1
  • Orally disintegrating tablets: For patients who have difficulty swallowing or compliance issues 3, 4

Critical Safety Warning About IV Administration

The FDA label explicitly states that olanzapine for injection is intended for intramuscular use only and must NOT be administered intravenously or subcutaneously. 1 This is a critical safety consideration that clinicians must observe.

Why IM is Preferred Over IV for Antipsychotics

Guidelines from the American Academy of Pediatrics recommend that intramuscular dosing of antipsychotics in the emergency department is the preferred parenteral route of administration rather than IV. 5 This recommendation stems from safety concerns, particularly regarding:

  • Cardiac risks: While IV haloperidol has been studied, it carries an FDA warning due to deaths associated with high doses and IV administration 5
  • QT prolongation: Olanzapine causes minimal QT prolongation (mean 2 ms), but the IV route could theoretically increase cardiac risks 5

IM Olanzapine Dosing for Acute Agitation

When parenteral olanzapine is indicated for acute agitation:

  • Standard dose: 10 mg IM 1, 5
  • Lower doses: 5 mg or 7.5 mg may be considered when clinical factors warrant 1
  • Geriatric/debilitated patients: 5 mg IM (or 2.5 mg for those predisposed to hypotension) 1
  • Repeat dosing: Subsequent doses up to 10 mg may be given, but not more frequently than 2 hours after the initial dose and 4 hours after the second dose 1
  • Maximum daily dose: Total daily doses greater than 30 mg have not been evaluated in clinical trials 1

Onset of Action and Efficacy

IM olanzapine demonstrates rapid effectiveness:

  • Onset: Significant reduction in agitation occurs within 15-30 minutes after injection 6, 4
  • Peak effect: Maximum benefit typically seen at 2 hours post-injection 6, 7
  • Efficacy: Comparable to or superior to IM haloperidol for acute agitation, with a more favorable side effect profile 5, 2, 6, 7

Reconstitution and Administration

The IM formulation requires proper preparation:

  • Reconstitution: Dissolve with 2.1 mL of Sterile Water for Injection to provide approximately 5 mg/mL 1
  • Use immediately: Must be used within 1 hour after reconstitution 1
  • Injection technique: Inject slowly, deep into the muscle mass 1

Critical Drug Incompatibilities

Do not combine IM olanzapine in a syringe with:

  • Diazepam injection: Causes precipitation 1
  • Haloperidol injection: Results in low pH that degrades olanzapine over time 1
  • Lorazepam injection: Should not be used for reconstitution as it causes delayed reconstitution time 1

Common Pitfall to Avoid

The most common error is attempting to administer olanzapine intravenously. This is contraindicated and potentially dangerous. 1 Always verify the route of administration before preparing any antipsychotic injection, as only the IM route is approved and safe for olanzapine.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.